EP Patent

EP1898941A2 — Controlled-release formulation useful for treating disorders associated with hepatitis c virus

Assigned to Merck Sharp and Dohme LLC · Expires 2008-03-19 · 18y expired

What this patent protects

Controlled release dosage formulations including at least one compound of Formulae (I) to (XXVI) herein and a controlled-release carrier and methods of treatment using the same as provided.

USPTO Abstract

Controlled release dosage formulations including at least one compound of Formulae (I) to (XXVI) herein and a controlled-release carrier and methods of treatment using the same as provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP1898941A2
Jurisdiction
EP
Classification
—
Expires
2008-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.